US HB7062 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 44-0)
Status: Introduced on May 28 2020 - 25% progression, died in committee
Action: 2020-05-28 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 28 2020 - 25% progression, died in committee
Action: 2020-05-28 - Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Eliminates cost-sharing under the Medicare prescription drug benefit and Medicare Advantage for insulin and associated medical supplies during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019). The bill also allows beneficiaries to receive their insulin and supplies via mail order during the emergency period.
Title
Affordable Insulin for the COVID–19 Emergency Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2020-05-28 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-05-28 | House | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
| 2020-05-28 | House | Introduced in House |
Subjects
Cardiovascular and respiratory health
Digestive and metabolic diseases
Drug therapy
Emergency medical services and trauma care
Health
Health care coverage and access
Health technology, devices, supplies
Infectious and parasitic diseases
Medicare
Prescription drugs
Digestive and metabolic diseases
Drug therapy
Emergency medical services and trauma care
Health
Health care coverage and access
Health technology, devices, supplies
Infectious and parasitic diseases
Medicare
Prescription drugs
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/house-bill/7062/all-info |
| Text | https://www.congress.gov/116/bills/hr7062/BILLS-116hr7062ih.pdf |
